Scientists in China report removing HIV from human DNA using gene-editing technology. Experts say the findings are promising but still far from a confirmed cure.

Researchers developed a CRISPR-based system that spreads through bacterial populations to disable antibiotic resistance genes ...

CRISPR Therapeutics AG recently reported its fourth-quarter and full-year 2025 results, showing revenue falling to US$0.864 million in Q4 and US$3.51 million for the year, alongside wider net losses ...

Researchers used CRISPR gene editing to selectively kill cancer cells with amplified oncogenes. In animal and cellular models ...

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025.

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

With this in mind, let's check out a blastoff-ready biotech stock you'll kick yourself for not buying in 2026. Image source: Getty Images.

A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance.

Sales of Casgevy, a gene-edited treatment developed with CRISPR Therapeutics, more than tripled compared to the third quarter, a performance analysts saw as a bright spot in Vertex's report.

A new highly sensitive light-based sensor can detect extremely low concentrations of cancer biomarkers in the blood.

Researchers at UC Santa Barbara have identified a new taste receptor in a dangerous species of mosquitos that could lead to ...